Paragraf, the only company in the world to mass produce graphene electronics using transfer-free graphene and standard semiconductor processes, has acquired Cardea Bio, the world’s leading producer of graphene-based biocompatible chips.
Paragraf, currently the only company in the world to mass produce graphene electronics using transfer-free graphene and standard semiconductor processes, has acquired Cardea Bio, a producer of graphene-based biocompatible chips. Cardea Bio is to be renamed Paragraf USA.
Bupa’s sustainability director Glyn Richards, discusses the interrelations between climate change and nature and why businesses need to champion regenerative practices.